The recommendations bring closer to approval new therapies for asthma, acute myeloid leukaemia, transfusion-dependent anaemia, diabetes, prostate cancer, schizophrenia and multiple sclerosis
The recommendations bring closer to approval new therapies for asthma, acute myeloid leukaemia, transfusion-dependent anaemia, diabetes, prostate cancer, schizophrenia and multiple sclerosis
The new website aims to help the NHS and health charities find potential volunteers to help support them during the coronavirus pandemic
The test will identify if a person has had the novel COVID-19 virus
Almac and MSD will initially work together in a two-year joint research programme
The research hub includes a biomedical database, scientific and clinical content, COVID-19-specific datasets, and more
The two treatments could ‘constitute an early stage and late stage treatment option for all COVID-19 patients’
Hospitalised patients with advanced COVID-19 who received remdesivir recovered faster than those given placebo
AstraZeneca has taken on development, worldwide manufacturing and distribution of the potential vaccine
Pharmaceutical sales were up 6% on the year ago period
ACCORD is a multicentre, seamless, Phase II adaptive randomisation platform trial to assess the efficacy and safety of multiple candidate agents
The daily UK count will now show the total number of deaths for anyone with a positive test across all settings
The firm said based on the data it would not be pursuing further development of the drug in GIST beyond its approved indication
Trial findings are particularly encouraging given that infants already had progressed disease
Research shows sharp drop in GP cancer referrals and public concern over seeking medical advice
The firm said it remains confident in meeting its 2020 expectations